Group 1 - The company announced the acquisition of 40% equity in Liaoning Guoke Hengtai Medical Technology Co., Ltd. from Shenyang Qianfu Yu Trading Partnership, which will result in the company holding 100% of the equity after the acquisition [1] - The initial valuation of the equity asset is set at 3.7658 million yuan, with the final price not exceeding the assessment results provided by the evaluation agency and the results filed with the state-owned property management authority [1] - The board of directors approved the acquisition without the need for a shareholders' meeting, indicating that the decision falls within the board's authority [1]

国家税务总局上海市税务局相关负责人表示，税务部门将持续发挥税收职能作用，以更精的数字赋能、 更优的生态协同，加力推动稳外资稳外贸11项措施落地生效，为浦东引领区更高水平对外开放贡献税务 力量。(记者郑昕) 上海市税务部门推出服务浦东引领区更高水平对外开放税收征管服务措施以来，政策效应持续扩面增 效，有效激发了外贸外资活力。数据显示，今年上半年，上海市浦东新区办理出口退(免)税超400亿 元，同比增长14.2%，离岸贸易印花税减免超2亿元，惠及1300户企业，外资再投资递延纳税金额同比 上升208.5%。 在生物医药领域，浦东新区在全市率先形成了美国食品药品监督管理局(FDA)小型企业认证税务事项实 施方案，助力中小医药企业享受海外认证费用减免，企业"走出去"合规服务能力领跑全国。"FDA认证 税务方案是小微企业的'及时雨'！"维光新航医疗科技(上海)有限公司财务人员戴新梅感慨。这家从事医 疗器械贸易的小微企业，在税务部门的帮助下顺利开具FDA小型企业认证税务证明，成功获得海外认证 费用减免。据了解，目前该政策已惠及8家药企，助力浦东新区生物医药产业国际化提速。 今年3月，上海市税务部门推出11项税收征管服务措 ...

Group 1 - Company Yanguang Health Management is acquiring an 18.0% stake in Shanghai Ronggong Company from Fanghou No.1 [1] - The company will also subscribe for an additional 9.58% stake in Shanghai Ronggong through a capital increase agreement, with a total investment of RMB 12.72 million [1] - Following the completion of the capital increase, Yanguang Health Management will hold a total of 25.9% of Shanghai Ronggong [1] Group 2 - Yanguang Health Management is purchasing a 51.0% stake in Wuhan Ronggong for RMB 5.1 million, which will make Wuhan Ronggong a subsidiary of the company [2] - Shanghai Ronggong focuses on providing innovative financial technology solutions in the medical industry through its self-developed SaaS platform [2] - Wuhan Ronggong is involved in the wholesale and retail of various medical devices and has a significant market presence in the medical supply chain [2] Group 3 - The company aims to become a diversified imaging service provider for the entire medical imaging industry chain [3] - The strategic integration with Shanghai Ronggong and Wuhan Ronggong is expected to enhance the company's reach and create more business opportunities [3] - The acquisitions will enrich the company's financial tools and business models, promoting innovative solutions in imaging services [3]